Trade Agreement: CETA / CFTA
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: Lowest/Lower Bid
Comprehensive Land Claim Agreement: No
Nature of Requirements:
Description:
To supply human papillomavirus vaccine (HPV) on an as and when requested basis to the province of Quebec.
Contract Period:
The period of the Contract is from date of award to March 31, 2019 with an option to extend the term of the Contract by up to three additional one-year periods under the same conditions.
Maximum Estimated Quantity for the firm year:
Human papillomavirus vaccine: 102,000 doses
This requirement falls within the Federal/Provincial/Territorial Group Purchasing Program for Drugs and Vaccines. Canada is acting as an agent on behalf of the provincial and territorial jurisdictions.
Designated Users will be obligated to purchase a minimum of 75% of the maximum estimated quantities. Any resulting contract will include the option to add new users at a price not to exceed the Contract price and subject to the same conditions of the Contract.
Basis of Selection:
A bid must comply with the requirements of the bid solicitation and meet all mandatory evaluation criteria to be declared responsive. The responsive bid with the lowest evaluated price will be recommended for award of a contract.
Delivery Date:
As and when requested. The first delivery is required for November 2018.
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Delivery Date: 26/04/2018
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
